Search Market Research Report
Genome Editing Market Size, Share Global Analysis Report, 2020–2026
Genome Editing Market Technology (CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), TALEN (Transcriptor-Activator-Like Effector Nuclease), ZFN (Zinc Finger Nucleases), Antisense, Others), By Application (Cell Line Engineering, Genetic Engineering, and Others), and End-User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026
Industry Insights
[188+ Pages Report] According to the report published by Facts Factors, the global genome editing market size was worth around USD 4,000 million in 2019 and is predicted to grow to around USD 9,500 million by 2026 with a compound annual growth rate (CAGR) of roughly 15% between 2020 and 2026. The report analyzes the global genome editing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the genome editing market.
The genome editing market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire genome editing market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in value (USD Million) from FY 2016 – 2026.
This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the genome editing industry. The report analyzes and declares the historical and current trends analysis of the genome editing industry and subsequently recommends the projected trends anticipated to be observed in the genome editing market during the upcoming years.
Key Insights from Primary Research
- As per our primary respondents, the China genome editing market is set to grow annually at a rate of around 15%
- It was established through primary research that the China genome editing market was valued at more than USD 4,000 million in 2019
- The robust industrialization in China is supposed to display the highest growth in the regional market as it is one of the developed economies.
- Increase investment in the healthcare sector is supposed to fuel market growth. The companies are supposed to invest in R&D to innovate the better product. Product invention will open new opportunities for the genome editing thus is expected to propel the industry demand in the upcoming years.
- The “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)” category, on the basis of technology segmentation, was the leading revenue-generating category accounting for more than 30.0% share, in 2019.
- The “Cell Line Engineering” category, on the basis of application segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.
- The “Pharmaceutical and Biotechnological Companies” category, on the basis of end-user segmentation, was the leading revenue-generating category accounting for more than 40.0% share, in 2019.
Key Recommendations from Analysts
- There is a huge demand for genome editing in developing regions such as the Asia Pacific, which is driving the healthcare industry in the regions.
- North America region is anticipated to a larger share of the genome editing market in the upcoming years.
- India's genome editing market is anticipated to rise at the highest rate between 2020 and 2026.
- Growing at a CAGR around 16.0%, China genome editing and mining market provides numerous opportunities for all of the involved stakeholders across the entire value chain
- Our analysts have identified “CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)”, “Cell Line Engineering” and “Pharmaceutical and Biotechnological Companies” categories as the leading investment pockets for genome editing market in terms of technology, application, and end-user segmentations respectively
Global Genome Editing Market Revenue Share in 2019 – By End-User
The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the genome editing industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.
Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the genome editing industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the genome editing market.
The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the genome editing industry. The genome editing market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.
The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the genome editing sector. Key strategic developments in the genome editing market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the genome editing market are appropriately highlighted in the report.
The global genome editing market is experiencing significant growth that is expected to continue over the upcoming years. A massive rise in the demand for cell line engineering and genetic engineering is likely to act as a key driver of the global genome editing market.
The genome editing market research report delivers an acute valuation and taxonomy of the genome editing industry by practically splitting the market on the basis of different technology, application, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 4,000.00 Million |
Projected Market Size in 2026 |
USD 9,500.00 Million |
CAGR Growth Rate |
15.0% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Editas Medicine, HorizonDiscovery, Integrated DNA Technologies, GenScript, Lonza Group, OriGene Technologies, SangamoBioSciences, Intellia Therapeutics, Merck, CRISPR Therapeutics and precision BioSciences, and Others |
Key Segment |
By Technology, Application, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
The regional segmentation of the genome editing industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the genome editing industry is provided for the leading economies of the world.
The genome editing market is segmented based on technology, application, and end-user. On the basis of technology segmentation, the market is classified into CRISPR (clustered regularly interspaced short palindromic repeats), TALEN (transcriptor-activator-like effector nuclease), ZFN (zinc finger nucleases), antisense, and others. In terms of application segmentation, the market is bifurcated into genetic engineering, cell-line engineering, and others. In terms of end-user segmentation, the market is bifurcated into pharmaceutical and biotechnological companies, academic and research institutes, and contract research organizations.
Some of the essential players operating in the genome editing market, but not restricted to include
- Transposagen Biopharmaceuticals
- Thermo Fisher Scientific
- Editas Medicine
- Horizon Discovery
- Integrated DNA Technologies
- GenScript
- Lonza Group
- OriGene Technologies
- Sangamo BioSciences
- Intellia Therapeutics
- Merck
- CRISPR Therapeutics
- Precision BioSciences
The taxonomy of the genome editing industry by its scope and segmentation is as follows:
By Technology Analysis
- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
- TALEN (Transcriptor-Activator-Like Effector Nuclease)
- ZFN (Zinc Finger Nucleases)
- Antisense
- Others
By Application Analysis
- Cell Line Engineering
- Genetic Engineering
- Others
By End-User Analysis
- Pharmaceutical and Biotechnological Companies
- Academic and Research Institutes
- Contract Research Organizations
By Regional Segmentation Analysis
- North America
- The U.S.
- Canada
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
Industry Major Market Players
- Transposagen Biopharmaceuticals
- Thermo Fisher Scientific
- Editas Medicine
- Horizon Discovery
- Integrated DNA Technologies
- GenScript
- Lonza Group
- OriGene Technologies
- Sangamo BioSciences
- Intellia Therapeutics
- Merck
- CRISPR Therapeutics
- Precision BioSciences
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors